| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| 173 | 143 | 169 | 182 | 180 | 177 | 196 | 212 | |
Growth YoY Revenue Growth YoY% | 4.2 | 23.6 | 15.8 | 16.5 | ||||
| 124 | 118 | 133 | 143 | 140 | 144 | 152 | 171 | |
| 49 | 25 | 35 | 39 | 40 | 33 | 44 | 40 | |
OPM OPM% | 28.5 | 17.8 | 21.0 | 21.5 | 22.1 | 18.6 | 22.3 | 19.1 |
| 3 | 115 | 5 | 16 | -5 | 14 | 4 | 4 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Depreciation DepreciationCr | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 |
PBT PBTCr | 47 | 135 | 35 | 49 | 29 | 40 | 41 | 37 |
| 12 | 18 | 9 | 13 | 7 | 10 | 11 | 9 | |
| 35 | 117 | 26 | 37 | 22 | 30 | 31 | 28 | |
Growth YoY PAT Growth YoY% | -36.6 | -74.5 | 16.3 | -23.4 | ||||
NPM NPM% | 20.2 | 82.0 | 15.6 | 20.3 | 12.3 | 16.9 | 15.6 | 13.3 |
| 21.1 | 71.0 | 15.9 | 22.3 | 13.4 | 18.1 | 18.5 | 17.1 |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| 173 | 143 | 169 | 182 | 180 | 177 | 196 | 212 | |
Growth YoY Revenue Growth YoY% | 4.2 | 23.6 | 15.8 | 16.5 | ||||
| 124 | 118 | 133 | 143 | 140 | 144 | 152 | 171 | |
| 49 | 25 | 35 | 39 | 40 | 33 | 44 | 40 | |
OPM OPM% | 28.5 | 17.8 | 21.0 | 21.5 | 22.1 | 18.6 | 22.3 | 19.1 |
| 3 | 115 | 5 | 16 | -5 | 14 | 4 | 4 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Depreciation DepreciationCr | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 |
PBT PBTCr | 47 | 135 | 35 | 49 | 29 | 40 | 41 | 37 |
| 12 | 18 | 9 | 13 | 7 | 10 | 11 | 9 | |
| 35 | 117 | 26 | 37 | 22 | 30 | 31 | 28 | |
Growth YoY PAT Growth YoY% | -36.6 | -74.5 | 16.3 | -23.4 | ||||
NPM NPM% | 20.2 | 82.0 | 15.6 | 20.3 | 12.3 | 16.9 | 15.6 | 13.3 |
| 21.1 | 71.0 | 15.9 | 22.3 | 13.4 | 18.1 | 18.5 | 17.1 |
| Financial Year | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
Revenue RevenueCr | 653 | 708 | 764 |
Growth Revenue Growth% | 8.3 | 14.7 | |
| 494 | 560 | 608 | |
| 160 | 147 | 157 | |
OPM OPM% | 24.4 | 20.8 | 20.5 |
| 95 | 29 | 17 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 2 |
Depreciation DepreciationCr | 21 | 21 | 24 |
PBT PBTCr | 233 | 154 | 148 |
| 50 | 39 | 37 | |
PAT PATCr | 183 | 115 | 111 |
Growth PAT Growth% | -37.1 | -48.5 | |
NPM NPM% | 28.0 | 16.3 | 14.5 |
| 110.8 | 69.6 | 67.0 |
| Financial Year | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
Revenue RevenueCr | 653 | 708 | 764 |
Growth Revenue Growth% | 8.3 | 14.7 | |
| 494 | 560 | 608 | |
| 160 | 147 | 157 | |
OPM OPM% | 24.4 | 20.8 | 20.5 |
| 95 | 29 | 17 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 2 |
Depreciation DepreciationCr | 21 | 21 | 24 |
PBT PBTCr | 233 | 154 | 148 |
| 50 | 39 | 37 | |
PAT PATCr | 183 | 115 | 111 |
Growth PAT Growth% | -37.1 | -48.5 | |
NPM NPM% | 28.0 | 16.3 | 14.5 |
| 110.8 | 69.6 | 67.0 |
| Financial Year | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 13 | 13 | 13 |
Reserves ReservesCr | 517 | 592 | 674 |
| 120 | 161 | 229 | |
| 7 | 27 | 21 | |
| 658 | 793 | 1,116 | |
| 465 | 559 | 670 | |
| 193 | 234 | 446 | |
| 658 | 793 | 1,116 |
| Financial Year | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 13 | 13 | 13 |
Reserves ReservesCr | 517 | 592 | 674 |
| 120 | 161 | 229 | |
| 7 | 27 | 21 | |
| 658 | 793 | 1,116 | |
| 465 | 559 | 670 | |
| 193 | 234 | 446 | |
| 658 | 793 | 1,116 |
| Financial Year | Mar 2025 | Mar 2026 |
|---|---|---|
| 78 | 57 | |
| -42 | 86 | |
| -27 | -21 | |
Net Cash Flow Net Cash FlowCr | 9 | 122 |
Free Cash Flow Free Cash FlowCr | 151 | -9 |
CFO To PAT CFO To PAT% | 42.5 | 49.1 |
CFO To EBITDA CFO To EBITDA% | 48.8 | 38.4 |
| Financial Year | Mar 2025 | Mar 2026 |
|---|---|---|
| 78 | 57 | |
| -42 | 86 | |
| -27 | -21 | |
Net Cash Flow Net Cash FlowCr | 9 | 122 |
Free Cash Flow Free Cash FlowCr | 151 | -9 |
CFO To PAT CFO To PAT% | 42.5 | 49.1 |
CFO To EBITDA CFO To EBITDA% | 48.8 | 38.4 |
| Financial Year | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|
Market Cap Market CapitalizationCr | 3,767 | 3,060 | 4,202 |
Price To Earnings Price To Earnings | 20.6 | 26.6 | 37.9 |
Price To Sales Price To Sales | 5.8 | 4.3 | 5.5 |
Price To Book Price To Book | 7.1 | 5.0 | 6.1 |
EV To EBITDA EV To EBITDA | 22.7 | 19.6 | 26.2 |
GPM GPM% | 60.0 | 57.4 | 57.4 |
OPM OPM% | 24.4 | 20.8 | 20.5 |
NPM NPM% | 28.0 | 16.3 | 14.5 |
ROCE ROCE% | 44.0 | 24.8 | 21.1 |
ROE ROE% | 34.5 | 19.0 | 16.1 |
ROA ROA% | 27.9 | 14.5 | 9.9 |
| Financial Year | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|
Market Cap Market CapitalizationCr | 3,767 | 3,060 | 4,202 |
Price To Earnings Price To Earnings | 20.6 | 26.6 | 37.9 |
Price To Sales Price To Sales | 5.8 | 4.3 | 5.5 |
Price To Book Price To Book | 7.1 | 5.0 | 6.1 |
EV To EBITDA EV To EBITDA | 22.7 | 19.6 | 26.2 |
GPM GPM% | 60.0 | 57.4 | 57.4 |
OPM OPM% | 24.4 | 20.8 | 20.5 |
NPM NPM% | 28.0 | 16.3 | 14.5 |
ROCE ROCE% | 44.0 | 24.8 | 21.1 |
ROE ROE% | 34.5 | 19.0 | 16.1 |
ROA ROA% | 27.9 | 14.5 | 9.9 |
| Market CapitalizationMkt CapCr | 6,147 | 5,024 | 4,284 | 4,202 | 4,194 | 2,901 | 2,757 |
| Close PriceClose₹ | 377.55 | 1,090.80 | 4,128.40 | 2,540.90 | 418.25 | 1,693.90 | 317.05 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 19.62 | 35.52 | 44.67 | 37.91 | 52.41 | 51.49 | 32.48 |
| Price To SalesPS | 2.69 | 6.99 | 6.86 | 5.50 | 4.06 | 3.34 | 3.66 |
| RevenueRevenueCr | 2,289 | 719 | 624 | 764 | 1,032 | 870 | 753 |
| Revenue Growth TTMRev Gr TTM% | 10.2% | 39.0% | 47.7% | 14.7% | 18.2% | 30.1% | |
| PAT Growth TTMPAT Gr TTM% | 39.0% | 60.2% | 95.7% | -48.5% | 40.7% | -64.3% |
| Market CapitalizationMkt CapCr | 6,147 | 5,024 | 4,284 | 4,202 | 4,194 | 2,901 | 2,757 |
| Close PriceClose₹ | 377.55 | 1,090.80 | 4,128.40 | 2,540.90 | 418.25 | 1,693.90 | 317.05 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 19.62 | 35.52 | 44.67 | 37.91 | 52.41 | 51.49 | 32.48 |
| Price To SalesPS | 2.69 | 6.99 | 6.86 | 5.50 | 4.06 | 3.34 | 3.66 |
| RevenueRevenueCr | 2,289 | 719 | 624 | 764 | 1,032 | 870 | 753 |
| Revenue Growth TTMRev Gr TTM% | 10.2% | 39.0% | 47.7% | 14.7% | 18.2% | 30.1% | |
| PAT Growth TTMPAT Gr TTM% | 39.0% | 60.2% | 95.7% | -48.5% | 40.7% | -64.3% |